Tianjin Chase Sun Pharmaceutical: Tianjin Chase Sun Pharmaceutical Co., Ltd. announced the interest payment of the first tranche of bonds issued to professional investors in 2021, due in 2024.
Tianjin Chase Sun Pharmaceutical: Announcement of Tianjin Hongri Pharmaceutical Co., Ltd. on the resale results and delisting of “21 Red Sun 01”
Tianjin Chase Sun Pharmaceutical: CSI Enterprise Bond Index's Tianjin Chase Sun Pharmaceutical publicly issued corporate bonds (first phase) for professional investors in 2021. This report is for the entrusted management affairs (2023).
Tianjin Chase Sun Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. 2024 Follow-up Rating Report
Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd.\'s public issuance of corporate bonds to professional investors in 2021 (first phase), 2023 interest payment announcement
Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds to professional investors in 2021 (Phase 1) fiduciary management report (2022)
Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds 2023 tracking rating report
Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds to professional investors in 2021 (first phase) 2022 interest payment announcement
Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd.'s 2021 Public Issuance of Corporate Bonds to Professional Investors (Phase I) Fiduciary Management Report (2021)
Red Sun Pharmaceutical: Tianjin Red Sun Pharmaceutical Co., Ltd. 2022 Follow-up Rating Report
Red Sun Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice
Red Sun Pharmaceutical: Announcement on the Company's Additional Public Issuance of Corporate Bonds (Phase I) to Professional Investors in 2021 to Raise Funds to Supervise Banks
Hongri Pharmaceutical: Announcement on the listing of Tianjin Hongri Pharmaceutical Co., Ltd.'s public offering of corporate bonds (first phase) to professional investors on the Shenzhen Stock Exchange in 2021
Hongri Pharmaceutical: Announcement on the results of the public issuance of corporate bonds (first phase) by Tianjin Hongri Pharmaceutical Co., Ltd. to professional investors in 2021
Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd.\'s 2021 Public Offering of Corporate Bonds (Phase I) Coupon Interest Rate Announcement to Professional Investors
Hongri Pharmaceutical: Announcement on Extending the Bookkeeping and Filing Period for Tianjin Hongri Pharmaceutical Co., Ltd.\'s Public Issuance of Corporate Bonds (Phase I) to Professional Investors in 2021 (Third Time)
Hongri Pharmaceutical: Announcement on extending the bookkeeping and filing period for the public issuance of corporate bonds (first phase) by Tianjin Hongri Pharmaceutical Co., Ltd. to professional investors in 2021 (second time)
Hongri Pharmaceutical: Announcement on extending the bookkeeping and filing period for the public issuance of corporate bonds (first phase) by Tianjin Hongri Pharmaceutical Co., Ltd. to professional investors in 2021
Hongri Pharmaceutical: Credit Rating Report for the Public Issuance of Corporate Bonds by Tianjin Hongri Pharmaceutical Co., Ltd. to Professional Investors in 2021
Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds (first phase) to professional investors in 2021 (subject to this)
No Data
No Data